ERBB, AEGY, BDSI & Extended Watchlist

Tranzbyte Corp. ERBB

We highlighted ERBB on Friday and the stock came out swinging, continuing the momentum that was building in the previous session.It came out of the gate strong, running quickly from a low of .0119 up as high as .0154. That marks a respectable intraday move of 29%As the stock pulls back off of that run, we’d like to see support hold over a penny, and will be monitoring the situation for any possible bounce opportunities.


Alternative Energy Partners, Inc. AEGY

We’ve had AEGY on our radar since last spring, and after a serious increase in recent trading activity, we wanted to bring it back into the conversation. The stock has been in full-on breakout mode for the past couple of sessions, and appears to want to gap up even further this morning.  What we are going to want to do is watch carefully for any possible dip-and-rip opportunities. Stocks that gain so much ground over so short a time-frame are susceptible to high volatility and sudden pullbacks, and are often followed by what can be very lucrative bounceplays for quick-witted traders.

This is another of the medical marijuana related stocks that we’ve been tracking for a long while. AEGY, in particular, operates pharmajanes.com an online dispensary for California residents, but the list of companies that we’ve tracked cover every part of the sector, from medical to legal cannabis, to growing apparatus, and more.

To list a few of the standouts we’ve tracked over an extended time: EAPH, FITX, CBIS, HEMP, PHOT, MJNA, SKTO, TRTC, EDXC, MWIPD, EXMT, CANN, MDBX, GWPH and that’s only a partial list. Cannabis has been allowing a lot of people to cash in via the stock market, and we expect the opportunities to keep coming.


BioDelivery Sciences International, Inc. BDSI
BDSI appeared in Friday’s Extended Watchlist and made a notable 16% intraday move, trading from a low of 8.18 to 9.49 on almost 15M shares traded. The spike in price and volume comes on the heels of Thursday’s PR regarding positive testing results for the pain medication the company has under development:

Extended Watchlist:
REVI, RITT, NWBO, MM, ALU, CLSN, HIHO, RNN